To Today's Drug Reps, Docs Just Say No

Monday, October 27, 2008

Contrary to popular belief, physicians are genuinely skeptical of drug sales reps, and are unwilling or unable to meet with them for more than a minute. That's one of the conclusions from a year-long analysis by Oliver Wyman of sales and marketing operations of pharmaceutical and biotechnology firms...

Source: pharmalive

Breaking News

Misreading Of Damaged DNA May Spur Tumor Formation

The DNA in our cells is constantly under assault from oxygen, the sun's radiation and environmental stresses...

Friday, November 21, 2008 Source: Emory University

Researcher Tricks Immune System In Diabetic Mice

The body's immune system hates strangers. When its security patrol spots a foreign...

Friday, November 21, 2008 Source: Northwestern University

Pure Insulin-Producing Cells Produced In Mouse

Singapore researchers have developed an unlimited number of pure insulin-producing...

Friday, November 21, 2008 Source: Agency for Science, Technology and Research (A*STAR), Singapore

Bad Cholesterol Inhibits The Breakdown Of Peripheral Fat

The so called bad cholesterol (LDL) inhibits the breakdown of fat in cells of...

Friday, November 21, 2008 Source: Karolinska Institutet

Oh, What a Feeling!

People who have lost the ability to interpret emotion after a severe brain injury...

Friday, November 21, 2008 Source: University of New South Wales

Stopping Germs From Ganging Up On Humans

Keeping germs from cooperating can delay the evolution of drug resistance more...

Friday, November 21, 2008 Source: University of Arizona

Scientists Discover New Species Of Ebola Virus

Scientists report the discovery of a new species of Ebola virus, provisionally...

Friday, November 21, 2008 Source: Public Library of Science
More Breaking News

Patent News

Barr Announces Agreements on Nasacort AQ, Allegra D-12 and Allegra Patent Challenges

Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that its subsidiary, Barr Laboratories, Inc...

Wednesday, November 19, 2008 Source: PRNewswire

Sanofi-Aventis (France) (SASY.PA) Settles Allergy Drugs Dispute; Barr Pharmaceuticals, Inc. (BRL) Announces Agreements on Nasacort(R) AQ, Allegra(R) D-12 and Allegra(R) Patent Challenges

Barr Pharmaceuticals, Inc. (NYSE: BRL - News) today announced that its subsidiary, Barr Laboratories, Inc...

Wednesday, November 19, 2008 Source: PRNewswire

Novartis Prepares for Looming Loss of Diovan Patent

Novartis AG is working on several drugs that will combine its new heart medicine...

Wednesday, November 19, 2008 Source: MarketWatch
More Patent News

Clinical Trials News

Amgen (AMGN) (JOBS), Takeda (JOBS), and Millennium (JOBS) Suspend Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer; Drug Test Stopped After Deaths

Amgen and Millennium: The Takeda Oncology Company, a subsidiary of Takeda Pharmaceutical...

Thursday, November 20, 2008 Source: PRNewswire

Neuromed Pharmaceuticals Completes Enrollment for Phase 3 Chronic Low Back Pain Clinical Trial of NMED-1077

Neuromed Pharmaceuticals, a biopharmaceutical company developing new and improved...

Thursday, November 20, 2008 Source: PRNewswire

Gentium Provides an Update on the Phase 3 Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease

Gentium S.p.A. (NASDAQ: GENT) announced today interim results from an independent...

Thursday, November 20, 2008 Source: BUSINESS WIRE
More Clinical Trials News

News Search

Search News By Keywords

News Sections

New Technologies

CoolSystem™
from Biocision
More New Technologies
advertisement
Advertisement (image not found)

Email Newsletter Sign-Up

Stay updated on the latest technologies and news with Biocompare's newsletters
(See samples here)









 Select All

Privacy Policy | Manage Subscriptions

Loading

Loading